Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis

Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis

US Patent 12140592 · Granted Nov 12, 2024

Estimated economic value: $636,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarkers for a systemic lupus erythematosus (SLE) disease activity immune inde2025
Biomarkers for a systemic lupus erythematosus (SLE) disease activity immune inde2025
Biomarkers for systemic lupus erythematosus disease activity, and intensity and 2023
Biomarkers for systemic lupus erythematosus disease activity, and intensity and 2023
Biomarkers for systemic lupus erythematosus disease activity, and intensity and 2019
Biomarkers for systemic lupus erythematosus disease activity, and intensity and 2019
Diagnostics and therapy of epstein-barr virus in autoimmune disorders2011
Anthrax compositions and methods of use and production2010
Assays and therapies for latent viral infection2008
Methods and reagents for diagnosis of autoantibodies2007
Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders2007
Diagnostics and therapy of epstein-barr virus in autoimmune disorders2007